Company Prestige Consumer Healthcare Inc. Deutsche Boerse AG

Equities

PBV

US74112D1019

Pharmaceuticals

Delayed Deutsche Boerse AG 15:01:10 17/06/2024 BST 5-day change 1st Jan Change
59 EUR -0.84% Intraday chart for Prestige Consumer Healthcare Inc. -1.67% +6.31%

Business Summary

Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Number of employees: 570

Sales per Business

USD in Million2023Weight2024Weight Delta
North American Over-the-counter Healthcare
85.2 %
974 86.3 % 958 85.2 % -1.59%
International Over-the-counter Healthcare
14.8 %
154 13.7 % 167 14.8 % +8.54%

Sales per region

USD in Million2023Weight2024Weight Delta
United States
78.8 %
953 84.5 % 886 78.8 % -7.00%
Rest of World
14.8 %
154 13.7 % 167 14.8 % +7.80%
North America
6.4 %
20 1.8 % 72 6.4 % +261.59%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 05/12/10
Director of Finance/CFO 49 11/09/16
Chief Operating Officer 63 31/03/18
Sales & Marketing 63 30/04/19
General Counsel - 31/05/18
General Counsel 58 31/10/16

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 31/12/14
Director/Board Member 71 01/02/21
Director/Board Member 59 30/04/20
Director/Board Member 53 31/07/23
Director/Board Member 75 25/05/16
Director/Board Member 70 31/12/05
Chief Executive Officer 60 05/12/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,595,366 49,247,262 ( 88.58 %) 5,680,000 ( 10.22 %) 88.58 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
16.75 %
8,361,581 16.75 % 538 M €
Vanguard Fiduciary Trust Co.
11.50 %
5,742,010 11.50 % 369 M €
Dimensional Fund Advisors LP
6.323 %
3,156,071 6.323 % 203 M €
Macquarie Investment Management Business Trust
5.850 %
2,919,914 5.850 % 188 M €
Ariel Investments LLC
5.131 %
2,560,991 5.131 % 165 M €
2,014,602 4.036 % 130 M €
Victory Capital Management, Inc. (Investment Management)
3.813 %
1,903,103 3.813 % 122 M €
Geode Capital Management LLC
2.405 %
1,200,583 2.405 % 77 M €
Invesco Advisers, Inc.
2.236 %
1,116,083 2.236 % 72 M €
Eaton Vance Management
2.143 %
1,069,789 2.143 % 69 M €

Company contact information

Prestige Consumer Healthcare, Inc.

660 White Plains Road Suite 250

10591, Tarrytown

+

http://www.prestigebrands.com
address Prestige Consumer Healthcare Inc.(PBV)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
64.25 USD
Average target price
73.5 USD
Spread / Average Target
+14.40%
Consensus
  1. Stock Market
  2. Equities
  3. PBH Stock
  4. PBV Stock
  5. Company Prestige Consumer Healthcare Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW